GTH Key Statistics, Chart & Performance
The current stock price of GTH is 4.025 USD. In the past month the price increased by 2.68%. In the past year, price increased by 27.78%.
GTH Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GTH. When comparing the yearly performance of all stocks, GTH is one of the better performing stocks in the market, outperforming 76.99% of all stocks.
GTH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GTH. GTH has a bad profitability rating. Also its financial health evaluation is rather negative.
GTH Financial Highlights
Over the last trailing twelve months GTH reported a non-GAAP Earnings per Share(EPS) of -3.54. The EPS decreased by -61.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| Debt/Equity | 0.05 |
GTH Forecast & Estimates
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
For the next year, analysts expect an EPS growth of 20.69% and a revenue growth 25.16% for GTH
GTH Ownership
GTH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.39 | 387.092B | ||
| AMGN | AMGEN INC | 17.06 | 198.053B | ||
| GILD | GILEAD SCIENCES INC | 17.07 | 185.32B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.48 | 116.409B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.91 | 80.573B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45.82 | 43.76B | ||
| INSM | INSMED INC | N/A | 32.21B | ||
| NTRA | NATERA INC | N/A | 27.199B | ||
| BIIB | BIOGEN INC | 13.02 | 27.192B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.47 | 20.623B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GTH
Company Profile
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
Company Info
GENETRON HOLDINGS LTD-ADR
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District
Beijing BEIJING 102206 CN
CEO: Sizhen Wang
Employees: 799
Phone: 861050907500
GENETRON HOLDINGS LTD-ADR / GTH FAQ
Can you describe the business of GENETRON HOLDINGS LTD-ADR?
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
What is the current price of GTH stock?
The current stock price of GTH is 4.025 USD. The price increased by 0.12% in the last trading session.
What is the dividend status of GENETRON HOLDINGS LTD-ADR?
GTH does not pay a dividend.
How is the ChartMill rating for GENETRON HOLDINGS LTD-ADR?
GTH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting GTH stock to perform?
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
Can you provide the ownership details for GTH stock?
You can find the ownership structure of GENETRON HOLDINGS LTD-ADR (GTH) on the Ownership tab.